Bristol-Myers sells Ind. facility to AstraZeneca

Home › Bristol-Myers sells Ind. facility to AstraZeneca

Bristol-Myers Squibb had signed an agreement in 2007 with AstraZeneca to jointly research, develop and commercialize diabetes drugs.

26.06	VW to invest up to $5bn in Tesla rival Rivian
26.06	Strategic use of soybean meal to maximize hog carcass weight during summer
26.06	Eastern North Pacific Tropical Weather Outlook
26.06	Atlantic Tropical Weather Outlook
26.06	Aer Lingus pilots begin industrial action over pay dispute
25.06	Water requirements in the summer
25.06	New model Is transforming the study of liver abscesses in cattle
25.06	Royal Mail buyer to make offer for all staff shares
More »

je.st